Laura Shaughnessy

1.3k total citations
33 papers, 959 citations indexed

About

Laura Shaughnessy is a scholar working on Public Health, Environmental and Occupational Health, Immunology and Surgery. According to data from OpenAlex, Laura Shaughnessy has authored 33 papers receiving a total of 959 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Public Health, Environmental and Occupational Health, 14 papers in Immunology and 13 papers in Surgery. Recurrent topics in Laura Shaughnessy's work include Pregnancy and Medication Impact (17 papers), Reproductive System and Pregnancy (13 papers) and Eosinophilic Esophagitis (11 papers). Laura Shaughnessy is often cited by papers focused on Pregnancy and Medication Impact (17 papers), Reproductive System and Pregnancy (13 papers) and Eosinophilic Esophagitis (11 papers). Laura Shaughnessy collaborates with scholars based in United States, Belgium and Switzerland. Laura Shaughnessy's co-authors include Frauke Förger, Marie Teil, Astrid van Tubergen, Gordana Kosutic, Jeff Simpson, Megan E. B. Clowse, John C. Pezzullo, Niels Ejskjær, Per M. Hellström and Anna Moltó and has published in prestigious journals such as Gastroenterology, American Journal of Obstetrics and Gynecology and Annals of the Rheumatic Diseases.

In The Last Decade

Laura Shaughnessy

32 papers receiving 931 citations

Peers

Countries citing papers authored by Laura Shaughnessy

Since Specialization

Citations

This map shows the geographic impact of Laura Shaughnessy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura Shaughnessy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura Shaughnessy more than expected).

Fields of papers citing papers by Laura Shaughnessy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laura Shaughnessy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura Shaughnessy. The network helps show where Laura Shaughnessy may publish in the future.

Co-authorship network of co-authors of Laura Shaughnessy

This figure shows the co-authorship network connecting the top 25 collaborators of Laura Shaughnessy. A scholar is included among the top collaborators of Laura Shaughnessy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laura Shaughnessy. Laura Shaughnessy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Developing and Refining the Pregnancy Algorithm CErtaInty Tool ( ACE ‐ IT ) for Validating Pregnancy Outcomes 2025 ·Clinical Pharmacology & Therapeutics ·Sonal Singh, (unknown), Susan E. Andrade, Lesley M. Butler, (unknown), (unknown), Simone Pinheiro, Laura Shaughnessy, (unknown), (unknown)	1
2	Determination of prednisolone concentration in human breast milk and plasma of breastfed infants: study protocol of a Swedish multicentre low-intervention clinical trial 2025 ·BMJ Open ·(unknown), Karin Hellgren, (unknown), (unknown), Erika Timby, (unknown), (unknown), (unknown), Laura Shaughnessy, (unknown)	1
3	Setting up mother–infant pair lactation studies with biobanking for research according to regulatory requirements 2025 ·British Journal of Clinical Pharmacology ·(unknown), Ida Björkgren, (unknown), Helena Backman, Jarl Hellman, Linda Englund‐Ögge, (unknown), (unknown), Andrea Wutte, (unknown), Paweł Baranczewski, Laura Shaughnessy	0
4	Population PK modeling of certolizumab pegol in pregnant women with chronic inflammatory diseases 2024 ·CPT Pharmacometrics & Systems Pharmacology ·(unknown), Jagdev Sidhu, Laura Shaughnessy, Rocío Lledó‐García, Vivek Dua, Marie Teil, Akash Khandelwal	1
5	Pregnancy Outcomes After Exposure to Certolizumab Pegol 2018 ·Arthritis & Rheumatology ·Megan E. B. Clowse, Angela E. Scheuerle, Christina Chambers, Anita Afzali, Alexa B. Kimball, John J. Cush, Maureen Cooney, Laura Shaughnessy, (unknown), Frauke Förger	117
6	388. Characteristics and outcomes of prospectively reported pregnancies exposed to certolizumab pegol from a safety database 2018 ·Pregnancy Hypertension ·Megan E. B. Clowse, Angela E. Scheuerle, Christina Chambers, Anita Afzali, Alexa B. Kimball, John J. Cush, Maureen Cooney, Laura Shaughnessy, (unknown), Frauke Förger	1
7	Minimal to no transfer of certolizumab pegol into breast milk: results from CRADLE, a prospective, postmarketing, multicentre, pharmacokinetic study 2017 ·Annals of the Rheumatic Diseases ·Megan E. B. Clowse, Frauke Förger, (unknown), John M. Thorp, Radboud J. E. M. Dolhain, Astrid van Tubergen, Laura Shaughnessy, Jeff Simpson, Marie Teil, Nathalie Toublanc, (unknown), Thomas W. Hale	115
8	Lack of placental transfer of certolizumab pegol during pregnancy: results from CRIB, a prospective, postmarketing, pharmacokinetic study 2017 ·Annals of the Rheumatic Diseases ·Xavier Mariette, Frauke Förger, Bincy Abraham, Ann D. Flynn, Anna Moltó, René-Marc Flipo, Astrid van Tubergen, Laura Shaughnessy, Jeff Simpson, Marie Teil, Eric Helmer, Maggie Haitian Wang, Eliza F. Chakravarty	255
9	OP0017 Lack of placental transfer of certolizumab pegol during pregnancy: results from crib, a prospective, postmarketing, multicenter, pharmacokinetic study 2017 ·Annals of the Rheumatic Diseases ·Xavier Mariette, (unknown), Frauke Förger, Anna Moltó, (unknown), Astrid van Tubergen, Laura Shaughnessy, J. A. Simpson, Marie Teil, Eric Helmer, (unknown), Eliza Chakravarty	8
10	692: Evaluating transfer of certolizumab pegol into breast milk: results from a prospective, postmarketing, multicenter pharmacokinetic study 2016 ·American Journal of Obstetrics and Gynecology ·John M. Thorp, Megan E. B. Clowse, Frauke Förger, (unknown), Radboud J. E. M. Dolhain, Astrid van Tubergen, Laura Shaughnessy, Jeff Simpson, Marie Teil, Nathalie Toublanc, (unknown), Thomas W. Hale	1
11	Pregnancy Outcomes in Subjects Exposed to Certolizumab Pegol 2015 ·The Journal of Rheumatology ·Megan E. B. Clowse, Douglas C. Wolf, Frauke Förger, John J. Cush, Amanda Golembesky, Laura Shaughnessy, Dirk De Cuyper, Uma Mahadevan	59
12	Tu1320 Pregnancy Outcomes After Exposure to Certolizumab Pegol: Updated Results From Safety Surveillance 2015 ·Gastroenterology ·Uma Mahadevan, Séverine Vermeire, Douglas C. Wolf, Frauke Förger, John J. Cush, Amanda Golembesky, Laura Shaughnessy, Dirk De Cuyper, (unknown), Megan E. B. Clowse	8
13	Long-term safety and efficacy of certolizumab pegol in combination with methotrexate in the treatment of rheumatoid arthritis: 5-year results from the RAPID 1 trial and open-label extension 2013 ·Annals of the Rheumatic Diseases ·Edward Keystone, Robert Landewé, Ronald van Vollenhoven, Bernard Combe, Vibeke Strand, Philip J. Mease, Laura Shaughnessy, (unknown), Désirée van der Heijde	41
14	THU0192 5-Year Results from the Rapid 1 Trial and Open-Label Extension: Long-Term Safety and Efficacy of Certolizumab Pegol in Combination with Methotrexate in the Treatment of Rheumatoid Arthritis 2013 ·Annals of the Rheumatic Diseases ·Edward Keystone, Robert Landewé, Ronald van Vollenhoven, Bernard Combe, Vibeke Strand, Philip J. Mease, Laura Shaughnessy, (unknown), D. van der Heijde	8
15	Safety and efficacy of ghrelin agonist TZP-101 in relieving symptoms in patients with diabetic gastroparesis: a randomized, placebo-controlled study 2010 ·Neurogastroenterology & Motility ·Niels Ejskjær, Georg Dimcevski, John M. Wo, Per M. Hellström, Lars Christian Gormsen, Irene Sarosiek, Eirik Søfteland, T Nowak, John C. Pezzullo, Laura Shaughnessy, Gordana Kosutic, Richard W. McCallum	85
16	Contribution of Protein Binding to the Pharmacokinetics of the Ghrelin Receptor Agonist TZP-101 in Healthy Volunteers and Adults with Symptomatic Gastroparesis 2009 ·Clinical Drug Investigation ·William A. Wargin, Helmut Thomas, (unknown), (unknown), Niels Ejskjær, María del Mar Gutiérrez, Laura Shaughnessy, Gordana Kosutic	11
17	Ghrelin receptor agonist (TZP‐101) accelerates gastric emptying in adults with diabetes and symptomatic gastroparesis 2009 ·Alimentary Pharmacology & Therapeutics ·Niels Ejskjær, Esben Thyssen Vestergaard, Per M. Hellström, Lars Christian Gormsen, Sten Madsbad, Jan L. Madsen, (unknown), John C. Pezzullo, Jens Sandahl Christiansen, Laura Shaughnessy, Gordana Kosutic	99
18	Ghrelin Agonist (TZP‐101): Safety, Pharmacokinetics and Pharmacodynamic Evaluation in Healthy Volunteers: A Phase I, First‐in‐Human Study 2008 ·The Journal of Clinical Pharmacology ·Kenneth C. Lasseter, Laura Shaughnessy, David Cummings, John C. Pezzullo, William A. Wargin, René Gagnon, (unknown), Gordana Kosutic	50
19	Lentiviral Vector-Based Models of Amyloid Pathology: From Cells to Animals 2005 ·Current Alzheimer Research ·Laura Shaughnessy, Mary Beth Thomas, John Wakefield, (unknown), (unknown), Frank Köentgen, Ram Ramabhadran	4
20	Novel Approaches to Models of Alzheimer's Disease Pathology for Drug Screening and Development 2004 ·Journal of Molecular Neuroscience ·Laura Shaughnessy, (unknown), Lori L. McMahon, (unknown), Mary Beth Thomas, John Wakefield, Frank Köentgen, Ram Ramabhadran	10

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact